Literature DB >> 17872498

TGF-beta suppresses EGF-induced MAPK signaling and proliferation in asthmatic epithelial cells.

Abdelhabib Semlali1, Eric Jacques, Sophie Plante, Sabrina Biardel, Julie Milot, Michel Laviolette, Louis-Philippe Boulet, Jamila Chakir.   

Abstract

Epithelial damage is an important pathophysiologic feature of asthma. Bronchial epithelium damage results in release of growth factors such as transforming growth factor (TGF)-beta(1) that may affect epithelial cell proliferation. The objective of our study is to evaluate the importance of TGF-beta(1) in regulating epithelial cell repair in asthma. We evaluated the effect of TGF-beta(1) on epidermal growth factor (EGF)-induced proliferation and downstream signaling in epithelial cells obtained from subjects with asthma compared with cells from healthy subjects. Cell proliferation was evaluated by bromodeoxyuridine incorporation. EGF receptor (EGFR), mitogen-activated protein kinase, TGF-beta receptors, Smads, Smad anchor for receptor activation (SARA), and cyclin-dependant kinase inhibitors were evaluated by Western blot. TGF-beta(1) and receptor expression were measured by RT-PCR and by enzyme-linked immunosorbent assay. Proliferation of epithelial cells at baseline and after EGF stimulation was significantly reduced in cells derived from subjects with asthma compared with cells obtained from healthy control subjects. EGF-induced ERK1/2 phosphorylation was reduced in epithelial cells from subjects with asthma compared with cells from healthy control subjects. This was paralleled with a reduced EGFR phosphorylation. Addition of TGF-beta(1) significantly decreased EGF-induced cell proliferation. TGF-beta(1) production was higher in asthmatic epithelial cells compared with normal cells. This was supported by a high expression of pSmad 3 and SARA in cells derived from individuals with asthma compared with normal subjects. Cycline-dependent kinase inhibitors were highly expressed in asthmatic compared with normal cells. Inhibition of TGF-beta(1) signaling in asthmatic epithelial cells restored EGFR, ERK1/2 phosphorylation, and cell proliferation induced by EGF. Our results suggest that TGF-beta restrains EGFR phosphorylation and downstream signaling in bronchial epithelial cells.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17872498     DOI: 10.1165/rcmb.2007-0031OC

Source DB:  PubMed          Journal:  Am J Respir Cell Mol Biol        ISSN: 1044-1549            Impact factor:   6.914


  13 in total

1.  The Immunosuppressive Microenvironment in BRCA1-IRIS-Overexpressing TNBC Tumors Is Induced by Bidirectional Interaction with Tumor-Associated Macrophages.

Authors:  Eman Sami; Bibbin T Paul; James A Koziol; Wael M ElShamy
Journal:  Cancer Res       Date:  2020-01-07       Impact factor: 12.701

2.  Morphine modulation of thrombospondin levels in astrocytes and its implications for neurite outgrowth and synapse formation.

Authors:  Hiroko Ikeda; Mayumi Miyatake; Noriaki Koshikawa; Kuniyasu Ochiai; Kiyoshi Yamada; Alexi Kiss; Maureen J Donlin; W Michael Panneton; James D Churchill; Michael Green; Akbar M Siddiqui; Andrew L Leinweber; Nicholas R Crews; Lubov A Ezerskiy; Victoria R Rendell; Mariana M Belcheva; Carmine J Coscia
Journal:  J Biol Chem       Date:  2010-10-02       Impact factor: 5.157

3.  Transcription factor Dlx2 protects from TGFβ-induced cell-cycle arrest and apoptosis.

Authors:  Mahmut Yilmaz; Dorothea Maass; Neha Tiwari; Lorenz Waldmeier; Petra Schmidt; François Lehembre; Gerhard Christofori
Journal:  EMBO J       Date:  2011-09-06       Impact factor: 11.598

Review 4.  New Player in Endosomal Trafficking: Differential Roles of Smad Anchor for Receptor Activation (SARA) Protein.

Authors:  Victoria Rozés-Salvador; Sebastian O Siri; Melina M Musri; Cecilia Conde
Journal:  Mol Cell Biol       Date:  2018-11-28       Impact factor: 4.272

5.  Role of SARA (SMAD anchor for receptor activation) in maintenance of epithelial cell phenotype.

Authors:  Constance E Runyan; Tomoko Hayashida; Susan Hubchak; Jessica F Curley; H William Schnaper
Journal:  J Biol Chem       Date:  2009-07-20       Impact factor: 5.157

6.  IL4 and IL-17A provide a Th2/Th17-polarized inflammatory milieu in favor of TGF-β1 to induce bronchial epithelial-mesenchymal transition (EMT).

Authors:  Xiaoying Ji; Jinxiu Li; Li Xu; Wenjing Wang; Ming Luo; Shuangling Luo; Libing Ma; Keng Li; Subo Gong; Long He; Zhijun Zhang; Ping Yang; Zhiguang Zhou; Xudong Xiang; Cong-Yi Wang
Journal:  Int J Clin Exp Pathol       Date:  2013-07-15

7.  Pentraxin 3 (PTX3) expression in allergic asthmatic airways: role in airway smooth muscle migration and chemokine production.

Authors:  Jingbo Zhang; Lianyu Shan; Latifa Koussih; Naresh Singh Redhu; Andrew J Halayko; Jamila Chakir; Abdelilah S Gounni
Journal:  PLoS One       Date:  2012-04-18       Impact factor: 3.240

8.  Expression and new exon mutations of the human Beta defensins and their association on colon cancer development.

Authors:  Abdelhabib Semlali; Abdullah Al Amri; Arezki Azzi; Omair Al Shahrani; Maha Arafah; Muhammad Kohailan; Abdulrahman M Aljebreen; Othman Alharbi; Majid A Almadi; Nahla Ali Azzam; Narasimha Reddy Parine; Mahmoud Rouabhia; Mohammad S Alanazi
Journal:  PLoS One       Date:  2015-06-03       Impact factor: 3.240

9.  Role Of Hif2α Oxygen Sensing Pathway In Bronchial Epithelial Club Cell Proliferation.

Authors:  Mar Torres-Capelli; Glenn Marsboom; Qilong Oscar Yang Li; Daniel Tello; Florinda Melendez Rodriguez; Tamara Alonso; Francisco Sanchez-Madrid; Francisco García-Rio; Julio Ancochea; Julián Aragonés
Journal:  Sci Rep       Date:  2016-05-06       Impact factor: 4.379

10.  Expression and Polymorphism of Toll-Like Receptor 4 and Effect on NF-κB Mediated Inflammation in Colon Cancer Patients.

Authors:  Abdelhabib Semlali; Narasimha Reddy Parine; Maha Arafah; Lamjed Mansour; Arezki Azzi; Omair Al Shahrani; Abdullah Al Amri; Jilani P Shaik; Abdulrahman M Aljebreen; Othman Alharbi; Majid A Almadi; Nahla Ali Azzam; Muhammad Kohailan; Mahmoud Rouabhia; Mohammad Saud Alanazi
Journal:  PLoS One       Date:  2016-01-15       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.